Cardiol Therapeutics Inc (CRDL)
2.15
-0.21
(-8.90%)
USD |
NASDAQ |
May 17, 16:00
2.29
+0.14
(+6.51%)
After-Hours: 20:00
Cardiol Therapeutics Total Assets (Quarterly): 23.04M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 23.04M |
December 31, 2023 | 27.67M |
September 30, 2023 | 31.67M |
June 30, 2023 | 35.59M |
March 31, 2023 | 38.95M |
December 31, 2022 | 45.70M |
September 30, 2022 | 49.99M |
June 30, 2022 | 57.64M |
March 31, 2022 | 63.62M |
December 31, 2021 | 68.92M |
September 30, 2021 | 24.88M |
June 30, 2021 | 29.64M |
Date | Value |
---|---|
March 31, 2021 | 16.71M |
December 31, 2020 | 12.46M |
September 30, 2020 | 18.27M |
June 30, 2020 | 20.08M |
March 31, 2020 | 9.414M |
December 31, 2019 | 11.87M |
September 30, 2019 | 13.83M |
June 30, 2019 | 15.64M |
March 31, 2019 | 17.16M |
December 31, 2018 | 18.12M |
September 30, 2018 | 10.13M |
December 31, 2017 | 2.561M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
9.414M
Minimum
Mar 2020
68.92M
Maximum
Dec 2021
30.78M
Average
26.27M
Median
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 6.475M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 8.191M |
Shareholders Equity (Quarterly) | 14.85M |